Brand-name vs compounded
MedVi vs Ro.co: Brand-Name or Compounded? (2026)
MedVi $299/mo vs Ro.co $39/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
On paper, MedVi and Ro.co sell the same thing: a prescription, a vial and a delivery date. In practice they are priced and staffed on different assumptions.
The dividing line is regulatory, not cosmetic: Ro.co works with product the FDA has reviewed and approved, while MedVi runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
Everything here is drawn from each provider's own published pricing and program detail, then extended into six- and twelve-month totals so the two become comparable. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $299/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Fastest route to a first shipment
- Ro.co — Online consultation, then home delivery.
- Longest public track record
- Ro.co — 40,215 patient reviews against 12,896.
The short version: MedVi vs Ro.co
Read the second row before the first: the advertised price and the price you actually run at are frequently different numbers.
| MedVi | Ro.co | |
|---|---|---|
| Advertised price | $179 promotional first month | Get started online for $39 |
| Rate after promotions | $299/mo | $39/mo |
| Pricing structure | Promotional first month, then standard rate | Promotional first month, then standard rate |
| Medication | Compounded semaglutide | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables |
| Tirzepatide | Not published | Not published |
| Price transparency | Published upfront | Partly published |
| Shipping | Fast, free shipping | Home delivery |
| Support model | No coaching program stated | Provider check-ins included |
| Patient reviews | 12,896 | 40,215 |
| eRxDoctor score | 9.2/10 | 7.5/10 |
Cost over a full course of treatment
Almost every complaint about telehealth GLP-1 pricing traces back to comparing month one instead of month twelve. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| MedVi | Ro.co | |
|---|---|---|
| First month | $179 | $39 |
| Months 2 onward | $299/mo | Not published |
| 6-month total | $1,674 | Not computable |
| 12-month total | $3,468 | Not computable |
| Best published plan | 3-month plan at $649 — $2,592/yr | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
Brand-name product versus a pharmacy preparation
Ro.co dispenses FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables: an approved finished drug, meaning the agency has reviewed both the evidence behind it and the facility that makes it.
Across from that, MedVi offers compounded semaglutide — prepared by a pharmacy rather than manufactured under approval. The price advantage and the reduced oversight are the same fact seen from two sides.
This is the decision to make deliberately rather than by price. If the regulatory status of what you are injecting weekly matters to you, that settles it toward Ro.co; if cost is the barrier that has kept you from treating at all, MedVi exists for a reason.
Inside the MedVi program
MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
Intake is simple online process, no clinic visits. Fulfillment is fast, free shipping. The commercial terms are promotional first month, then standard rate, published upfront.
What continues after the first shipment: 24/7 support from certified medical professionals. Formulary: compounded semaglutide.
MedVi pros
- Three-month plan available at $649 (about $216/month) for patients who commit
- Simple online process with no clinic visits required
- 24/7 support from certified medical professionals
- Clinically dosed compounded semaglutide
MedVi cons
- Compounded medication only, no branded Ozempic or Wegovy
- No published outcome or weight loss guarantee
- Price increases sharply after the first month, $299 for a standalone month
The cost of choosing this over Ro.co: the price roughly doubles to $299 once the promotional month ends.
Ro.co in detail
The pitch is the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all. Get Started Online for Just $39
Getting started means online consultation, after which home delivery. Pricing runs on a promotional first month, then standard rate basis, partly published.
On the clinical side, established full-service platform with clinician oversight, prescribing FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- No hidden fees; pricing disclosed before you complete your consultation
- FDA-approved finished medication, not compounded
- Established, full-service platform with strong brand trust
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
Ro.co cons
- Less price-competitive than compounded-only platforms for budget-driven patients
- Ongoing medication pricing varies and can be high depending on the plan
- Branded and FDA-approved medications cost significantly more than compounded alternatives
The reservation worth holding, particularly next to MedVi: an FDA-approved finished medication costs multiples of a compounded vial.
Who should choose MedVi, and who should choose Ro.co
Choose MedVi if:
- you want the full price in front of you before completing an intake
- you are willing to commit for a term in exchange for a lower effective rate (3-month plan at $649)
- you would get real value from a genuinely low promotional entry point with 24/7 clinical support behind it
- the level of clinical contact suits you: 24/7 support from certified medical professionals
Choose Ro.co if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: online consultation
- you want an FDA-approved finished medication rather than a compounded preparation
- the monthly rate is the constraint — $39/mo against $299/mo
The compromises on both sides
On price. Ro.co is the cheaper program at $39/mo against $299/mo. What Ro.co gives up for that is an FDA-approved finished medication costs multiples of a compounded vial; what MedVi charges for is a genuinely low promotional entry point with 24/7 clinical support behind it.
On medication. MedVi covers compounded semaglutide; Ro.co covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
On clinical contact. The support models differ — 24/7 support from certified medical professionals against established full-service platform with clinician oversight — and that difference is felt in week two, not week one.
On predictability. Promotional first month, then standard rate versus promotional first month, then standard rate. Whichever you pick, get the maintenance-dose price in writing at intake.
The clinical evidence, separated from the marketing
Weight loss percentages quoted in telehealth marketing come from trials neither MedVi nor Ro.co ran. Here is the source material, and what regulators say alongside it.
The FDA has published specific concerns about unapproved GLP-1 drugs sold for weight loss, including dosing errors made when patients measure their own doses, per FDA.
The FDA maintains a standing page on medications containing semaglutide, including what separates an approved product from a copy, per FDA.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
MedVi vs Ro.co: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Is Ro.co cheaper than MedVi?
Yes, on the ongoing rate. Ro.co runs $39/mo once promotional pricing ends, against $299/mo at MedVi — a difference of 7.7x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which has more patient reviews, MedVi or Ro.co?
Ro.co, with 40,215 against 12,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do MedVi or Ro.co take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Is MedVi or Ro.co better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. Ro.co publishes established full-service platform with clinician oversight, which is the more useful thing to buy at the start.
Can I switch from MedVi to Ro.co later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Do MedVi and Ro.co prescribe the same medication?
No. MedVi dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application; Ro.co dispenses brand-name, FDA-approved finished medication. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
MedVi's case is a genuinely low promotional entry point with 24/7 clinical support behind it; its cost: the price roughly doubles to $299 once the promotional month ends.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- MedVi vs Mochi HealthBudget vs premium
- MedVi vs NoviBudget vs premium
- Embody vs Ro.coBrand-name vs compounded
- Wellorithm vs Ro.coBrand-name vs compounded
- Ro.co vs MaximusBrand-name vs compounded
- Hers vs MeasuredBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or Ro.co, and does not sell treatment. Read our ranking methodology.